An all party parliamentary group (APPG) has been established to raise the profile of the UK life sciences sector.
Launched at a parliament event today, the group aims to raise awareness and understanding of the contribution the sector provides to health and wealth of the UK.
“Life sciences is the quintessential high-tech, innovative sector that we should prioritise for the 21st century economy,” says the group’s chair Kit Malthouse. “In addition to its economic impact, at its heart are innovations and therapies that benefit patients and the public.”
Life Sciences UK (LSUK) – which is made up of the ABPI, the BIA, the Association of British Healthcare Industries (ABHI), and the British In Vitro Diagnostics Association (BIVDA) – will provide secretariat for the group.
“The UK life sciences sector plays a key role in driving investment in science and health research and in developing life-changing medicines and technologies,” says Alison Clough, acting CEO of the ABPI. “The establishment of the APPG provides industry with an essential forum to work with parliamentarians to look at ways to improve the current ‘bed to bedside’ medicine pathway and to ensure that patients are getting access to the latest innovative treatments.”